 
 
| S No | Title of Project | Name of P.I. | Funding Agency | Amount | Date of sanction & Duration | 
| 1. | Evaluation of 1p and 19q chromosome status in oligodendroglial tumors | Dr. SushilaJaiswal | SGPGIMS | Rs. 5 lacs | Two years | 
| 2. | Role of serum biomarker | Dr. KuntalKanti Das, S.Jaiswal (Co-I) | SGPGIMS | Rs. 5 lacs | Two years | 
| 3. | Role of Factor-H Related Proteins in Complement-3 Glomerulopathy | Dr. Pallavi Prasad | SGPGIMS | Rs. 4.56 lacs | 11.01.2021 (Two years) | 
| 4. | Role of circulating tumor DNA EGFR mutations in Disease Monitoring of Non-small-cell Lung Carcinoma | Dr.Raghavendra L | SGPGIMS | Rs. 5 lacs | Aug 2019 (two years) | 
| 5. | Title Role of IHC in subtyping & differentiating Progressive Familial Intrahepatic Cholestasis (PFIC) from other causes of Pediatric Cholestatic Disease | Dr. Neha Nigam | SGPGIMS | Rs. 5 lacs | 23.12.2020 | 
| S No | Title of Project | Name of P.I. | Funding Agency | Amount | Date of sanction & Duration | 
| 1. | Circulating microparticles & monocyte activation in IgA Nephropathy | Dr. V. Agrawal | SERB-DST | Rs.45 lacs | 2019 | 
| 2. | Circulating Endothelial Microparticles and Microvascular injury in Renal Allograft Dysfunction | Dr. V. Agrawal | ICMR | Rs.45 lacs | 2019 | 
| 3. | Indigenization and Improvisation of Puncher Gun for Manual Tissue Microarray Contruction | Dr. V. Agrawal | IIT-Kanpur | Rs.10 lacs | 2018 | 
| 4. | Metabolomic profile of ampullary carcinoma | Dr. Raghavendra | ICMR | Rs.40 lacs | Approved on 20-03-2020 for two years 
 
 |